Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics

For the quarter ended December 2023, Edwards Lifesciences (EW) reported revenue of $1.53 billion, up 13.8% over the same period last year. EPS came in at$ 0.64, compared to $0.64 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of$ 1.5 billion, representing a surprise of +2.27%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.64.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how ...